---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-005165"
form_type: "8-K/A"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2026-01-16T23:59:59+00:00"
generated_at: "2026-05-16T09:44:35.165173+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma completes $2.28M additional unregistered offering, issues 1.5M shares

## Summary
- From May 26, 2025 to Jan 6, 2026, ABVC accepted additional subscriptions totaling $2,275,468 under same terms as prior Reg S offering.
- Issued 1,500,250 shares of common stock at prices ranging from $1.00 to $1.95 per share.
- Shares represent approximately 5.92% of outstanding common stock as of filing date.
- All purchasers are non-U.S. persons (accredited investors); voting rights transferred to Chairman Eugene Jiang via proxy agreement.

## SEC filing metadata
- accession: 0001213900-26-005165
- form_type: 8-K/A
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2026-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/0001213900-26-005165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/ea0272768-8ka1_abvc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-005165
- JSON: https://secwatch.observer/filing/0001213900-26-005165.json
- Plain text: https://secwatch.observer/filing/0001213900-26-005165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.